Case Study | October 06, 2011

Tomosynthesis Technology: A Key Differentiator for Dedicated Women’s Imagers

Women’s Center for Radiology, Orlando, Florida

Tomosynthesis Technology: A Key Differentiator for Dedicated Women’s Imagers
Tomosynthesis Technology: A Key Differentiator for Dedicated Women’s Imagers

The sign outside the Women’s Center for Radiology in Orlando, Florida, announces the arrival of 3D mammography. Susan Curry, M.D., founder and medical director, wants to get the message out to women in Central Florida about 3D mammography and the difference it can make in the early detection of breast cancer.

In April of this year, the Women’s Center became the first imaging facility in Orlando and one of only a handful of centers in the country to offer 3D mammograms. “Saving lives involves remaining cutting edge,” explains Dr. Curry. “We installed Hologic’s Selenia Dimensions digital tomosynthesis system because we believe it will help us to find cancer early, so we can make a significant difference in our patients’ lives. We felt the technology was so superior, we purchased a second Dimensions system in July.”

Leading the way with innovative and effective imaging technology isn’t new for the Women’s Center.  When Dr. Curry founded the Women’s Center for Radiology 30 years ago, its mission was to improve the survival rates for women with breast cancer. The Center brought together dedicated women’s imagers with the most advanced imaging technology available and set the standard for care in breast imaging.  

In 2004, the Women’s Center was the first imaging center in Central Florida to transition from analog to digital mammography with the installation of five Hologic Selenia digital mammography systems. “We were years ahead of other facilities implementing digital mammography,” explains Dr. Curry. “Digital technology is a better way to read mammograms. We can see more and find cancers in an earlier state.”

Dr. Curry believes tomosynthesis is enabling her staff to find smaller cancers at earlier stages. “The goal is to find cancer early, when it can be cured,” states Dr. Curry. “We’re trying to find really small cancers to improve the outcome. With tomosynthesis, we found a 7 millimeter cancer and, as a result, that patient may not need chemotherapy.”

Three radiologists and seven technicians focus solely on breast mammography, performing more than 35,000 mammograms annually. Additional staff provides breast MRI and ultrasound, DEXA scans, ductograms and biopsies, including stereotactic breast biopsies using Hologic’s ATEC breast biopsy and excision system and the MultiCare Platinum stereotactic breast biopsy guidance system.

Several times a month, the Women’s Center’s mobile imaging van, outfitted with a Selenia 2D digital mammography system and Hologic’s Sahara clinical bone sonometer, travels to local businesses, including Disney World and Universal Studios, to bring life-saving imaging services to women who can’t travel to the Center.

Making a Difference for Dense Breasts and High Risk Women
Dr. Curry had been following the progress of tomosynthesis technology through papers and conferences, and when she had an opportunity last year to experience the technology firsthand, she was excited about the chance. “I observed Hologic’s tomosynthesis system at work in the University Hospital in Turin, Italy,” states Dr. Curry. “The images were just remarkable and that pretty much answered any questions we had about implementing this technology. “

Dr. Curry reports that tomosynthesis will make a real difference in the Center’s ability to diagnosis patients with dense breasts or other high-risk factors. “With a two-dimensional mammogram, dense tissue can obscure breast cancer,” explains Dr. Curry. “If you can’t find the architectural distortions, which may be the only finding you have with an invasive tumor, then you can miss the tumor.

“One analogy I like is mammography is like a book,” adds Dr. Curry.  “With two-dimensional digital mammography, you can see the front and back cover and you learn a little bit about what is in the book, but everything in-between is obscured, as in a dense breast. With tomosynthesis you can see what’s inside, page by page. It’s not just a better image. It’s a more complete image.”

Dr. Curry continues, “The 3D tomosynthesis images are incredible and give us confidence in our diagnosis. We feel really confident we haven’t missed anything that will cause a problem next year or that the patient will discover later. I think there’s less stress when you read tomosynthesis mammograms.”

Improving the Outcomes
With only two tomosynthesis systems and approximately 150 patients a day, the Women’s Center uses a breast cancer risk assessment tool known as the “Gail model” to estimate a woman’s risk of developing invasive breast cancer over specific periods. Named after Dr. Mitchell Gail, Senior Investigator in the Biostatistics Branch of NCI’s Division of Cancer Epidemiology and Genetics, the model uses a woman’s own personal medical history (number of previous breast biopsies and the presence of atypical hyperplasia in any previous breast biopsy specimen), her own reproductive history (age at the start of menstruation and age at the first live birth of a child) and the history of breast cancer among her first-degree relatives (mother, sisters, daughters).

If a woman has an elevated Gail Model or high risk factors, she has a 2D + 3D mammogram. Plus, Dr. Curry reports, “Women come to our center because we have the most advanced technology available, and if they ask for the 3D exam, they get it.

“We’re here to take care of the patient, which is why our technicians like the Selenia Dimensions system,” Dr. Curry continues. “It’s easy to position the patient, and the Hologic FAST Paddle tilting paddle system makes the compression more comfortable for the patient. But, the greatest reason our technicians like tomosynthesis is because they do not have to take additional views. Recalls are difficult for the patient and time-consuming for the technician.”

Dr. Curry would like all Orlando women to know that tomosynthesis can help distinguish harmless abnormalities from real tumors – that means fewer callbacks and less anxiety. “If women know more about tomosynthesis, more women will request the three-dimensional exam.

“Today, with smaller cancers found earlier, women may not need chemotherapy or radiation treatment, which is a much better outcome for the patient,” Dr. Curry concludes.

The comments in this article are the opinions and personal stories of the individuals quoted and not necessarily those of Hologic. Hologic, ATEC, Dimensions, FAST Paddle, MultiCare, Sahara and Selenia are trademarks and/or registered trademarks of Hologic Inc. and/or its subsidiaries in the United States and/or other countries.

Case study supplied by Hologic.

Related Content

Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.